3D Printed Treatment Options | The CheckRare Brief @checkrare
3D Printed Treatment Options | The CheckRare Brief  @checkrare
Uploaded November 2026 | Updated November 2026, 19 hours ago
In this episode, we discuss a new formulation of treatment for HAE, the FDA approval of Voceryq for recurrent respiratory papillomatosis, and 3D printed treatment options.

Produced by CheckRare.

Explore additional CME activities, physician interviews, podcasts, and rare disease resources at CheckRare.com. Subscribe to the CheckRare Podcast Network for the latest rare disease education, expert interviews, and weekly news.

Part of the CheckRare Podcast Network: Trusted conversations, news, education, and expert insights across the rare disease community.
3D Printed Treatment Options | The CheckRare BriefResults From the PROGRESS Study of Zilurgisertib in Patients With FOPPhase 3 OASIS Study Shows Promise of Oral Olorofim for Invasive AspergillosisNew Stem Cell Method Could Advance Research Into Spinal Muscular AtrophyInterim PHINDER Analyses in Interstitial Lung DiseaseCh 3: VALIANT Results on the Longer-Term Impact of EmpaveliFDA Approves New Therapies for MPS IIIA and SMA | The CheckRare Brief Ep 8Fabry Disease: Patients Real-World Problems and How to Manage ThemA Family’s Journey with Prader-Willi SyndromeCongenital Hyperinsulinism Diagnosis and ManagementResults from the CALIBRATE Clinical Trial in Patients With Autosomal Dominant Hypocalcemia Type 1Decoding Delays, Connecting the Care: The Challenge of Diagnosing Rare Endocrine Disorders
CheckRare |

3D Printed Treatment Options | The CheckRare Brief

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER